Another promising approach might be the application of CCK2R targeted therapy in an adjuvant setting, in a comparable way to the use of radioiodine in the treatment of differentiated thyroid carcinoma after total thyroidectomy. This evidence concerns the gene CCKBR and differentiated thyroid carcinoma.